TY - JOUR
T1 - Recent Advances in Understanding the Micro- and Nanoscale Phenomena of Amorphous Solid Dispersions
AU - Ricarte, Ralm G.
AU - Van Zee, Nicholas J.
AU - Li, Ziang
AU - Johnson, Lindsay M.
AU - Lodge, Timothy P.
AU - Hillmyer, Marc A.
N1 - Publisher Copyright:
© 2019 American Chemical Society.
PY - 2019/5/31
Y1 - 2019/5/31
N2 - Many pharmaceutical drugs in the marketplace and discovery pipeline suffer from poor aqueous solubility, thereby limiting their effectiveness for oral delivery. The use of an amorphous solid dispersion (ASD), a mixture of an active pharmaceutical ingredient and a polymer excipient, greatly enhances the aqueous dissolution performance of a drug without the need for chemical modification. Although this method is versatile and scalable, deficient understanding of the interactions between drugs and polymers inhibits ASD rational design. This current Review details recent progress in understanding the mechanisms that control ASD performance. In the solid-state, the use of high-resolution theoretical, computational, and experimental tools resolved the influence of drug/polymer phase behavior and dynamics on stability during storage. During dissolution in aqueous media, novel characterization methods revealed that ASDs can form complex nanostructures, which maintain and improve supersaturation of the drug. The studies discussed here illustrate that nanoscale phenomena, which have been directly observed and quantified, strongly affect the stability and bioavailability of ASD systems, and provide a promising direction for optimizing drug/polymer formulations.
AB - Many pharmaceutical drugs in the marketplace and discovery pipeline suffer from poor aqueous solubility, thereby limiting their effectiveness for oral delivery. The use of an amorphous solid dispersion (ASD), a mixture of an active pharmaceutical ingredient and a polymer excipient, greatly enhances the aqueous dissolution performance of a drug without the need for chemical modification. Although this method is versatile and scalable, deficient understanding of the interactions between drugs and polymers inhibits ASD rational design. This current Review details recent progress in understanding the mechanisms that control ASD performance. In the solid-state, the use of high-resolution theoretical, computational, and experimental tools resolved the influence of drug/polymer phase behavior and dynamics on stability during storage. During dissolution in aqueous media, novel characterization methods revealed that ASDs can form complex nanostructures, which maintain and improve supersaturation of the drug. The studies discussed here illustrate that nanoscale phenomena, which have been directly observed and quantified, strongly affect the stability and bioavailability of ASD systems, and provide a promising direction for optimizing drug/polymer formulations.
KW - amorphous solid dispersions
KW - drug-polymer interactions
KW - solubility enhancement
UR - http://www.scopus.com/inward/record.url?scp=85072641817&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072641817&partnerID=8YFLogxK
U2 - 10.1021/acs.molpharmaceut.9b00601
DO - 10.1021/acs.molpharmaceut.9b00601
M3 - Article
C2 - 31487183
AN - SCOPUS:85072641817
SN - 1543-8384
VL - 16
SP - 4089
EP - 4103
JO - Molecular pharmaceutics
JF - Molecular pharmaceutics
IS - 10
ER -